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The central theme of this Doctoral Thesis is the role of serotonin in regulating social 
behavior in individuals at familial risk for MDD.  
Experimentally testing the role of serotonin in regulating human social behavior 
is difficult for several reasons. First, there are limited experimental options in terms of 
serotonin manipulation. ATD can be used to safely study the effects of acute reductions 
in brain serotonin (Young, 2013a). Nevertheless, for ethical reasons ATD studies are 
confined to laboratory settings (Young, 2013a). A more long-term depletion of serotonin 
is considered unethical (Young, 2013b).  
SSRIs may be used to study the effects of increases in brain serotonin on human 
social behavior, but side effects such as nausea, dry mouth, or drowsiness are often high-
er after SSRI administration than placebo (Crockett, Clark, Hauser, & Robbins, 2010; 
Paul, Gray, Love, & Lange, 2007), thereby increasing the risk of participant un-blinding 
(Crockett & Fehr, 2014). An alternative for experimentally increasing brain levels of 
serotonin is tryptophan, which produces very few side effects, no more than placebo 
(Moskowitz et al., 2001; Thomson et al., 1982).  
Second, there is limited availability of good laboratory tasks to assess aspects of 
human social interaction with sufficient ecological validity. The commentary paper de-
scribed in Chapter 3 discusses the ecological validity of social behavior assessments that 
have been used in past studies involving manipulation of the human brain serotonin sys-
tem (Hogenelst, Schoevers, & aan het Rot, 2015b). We showed that while most studies 
found that alterations in serotonin lead to changes in aspects of social interaction, the 
laboratory measures used generally had limited ecological validity. Thus the relevance 
for real-life interaction often remained unclear.  
We also showed that only two past studies assessed the effects of increases of 
serotonin on social behavior in daily life (Moskowitz et al., 2001; aan het Rot et al., 
2006). In these studies, behaviors were sampled using the Social Behavior Inventory 
(Moskowitz, 1994) and assessed using EMA (see also Moskowitz & Sadikaj, 2012). 
EMA can be used to intensively and repeatedly assess people’s thoughts, feelings, and 
behaviors in everyday situations (Conner and Mehl, 2012) and is considered to have high 
ecological validity (Moskowitz & Young, 2006). 
To mitigate the limitations of past studies on the role of serotonin in social be-
havior, in Study 1 of this Doctoral Thesis we used laboratory measures with high ecolog-
ical validity to assess the effects of ATD on social behavior in FH+ individuals. In Study 
2 we used EMA to assess the effects of repeated tryptophan administration on the real-




Study 1: Effects of ATD on empathic accuracy, speech, and behav-
ioral mimicry 
ATD may be used as a model to study the development of depression through changes in 
aspects of social interaction and mood (Figure 3). By and large the studies discussed in 
Chapter 1 indicate that in never-depressed individuals ATD induces a negative evaluation 
of and impairs the recognition of facial social stimuli (aan het Rot et al., 2010; Beacher et 
al., 2011; Harmer et al., 2003; Passamonti et al., 2012; van der Veen et al., 2007; Wil-
liams et al., 2007). Further, in Chapter 1 I argued that in FH+ individuals, more so than in 
FH- individuals, ATD may negatively influence the processing of affective and social 
stimuli (Feder et al., 2011; Firk and Markus, 2008; van der Veen et al., 2007). It is con-
ceivable that correct perception of social stimuli is important for forming an accurate 
impression of another person’s expressed emotion, which subsequently aids accurate 
empathic responding to that person. It has been suggested that the impaired processing of 
social stimuli as induced by acutely low serotonin, may negatively influence empathy 
(Williams et al., 2007). If acutely reduced serotonin function indeed impairs ones em-
pathic abilities then this may explain why depressed patients, who often show reduced 
serotonin function (Albert et al., 2012; Mann, 2013), often also show impairments in both 
affective and cognitive empathy (Schreiter et al., 2013).  
Study 1 primarily evaluated the effects of ATD on empathic accuracy (EA), a 
form of cognitive empathy in FH+ individuals and FH- individuals. EA was assessed 
using a laboratory task involving videos of other people (targets) talking about emotional 
life events (aan het Rot & Hogenelst, 2014; Zaki, Bolger, & Ochsner, 2008). The task 
considers the emotional expressivity of the targets. During real-life social interactions, 
facial expressions are dynamic social signals rather than static social stimuli. Using video 
stimuli and considering target expressivity was expected to greatly increase the ecologi-
cal validity of the data obtained (Ambadar, Schooler, & Cohn, 2005; Zaki & Ochsner, 
2009). Studying the effects of ATD on EA was considered a significant step forward 
from past studies that assessed the effects of ATD on the recognition of static facial ex-
pressions (e.g., aan het Rot et al., 2010; Harmer et al., 2003; van der Veen et al., 2007). 
 
In the context of Study 1 the following hypotheses were formulated concerning the ef-
fects of ATD on EA: 
 
1.1 ATD will reduce EA, particularly for videos with negative emotional content. 
1.2 The effects of ATD on EA will be more pronounced in FH+ individuals than in 
FH- individuals. 
 
The testing of these hypotheses is described in Chapter 4.  
Chapter 2 
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Study 1 secondarily examined the effects of ATD on speech and behavioral mimicry in 
FH+ and FH- individuals. This idea was based on previous research showing that in nev-
er-depressed individuals, ATD can negatively affect aspects of social functioning (e.g., 
Crockett et al., 2010; Wood et al., 2006). However, as the laboratory measures used to 
test this had low ecological validity the relevance of the studies’ findings for real-life 
interaction remains unclear (cf. Hogenelst et al., 2015b) (Chapter 3).  
Speech is an important aspect of everyday social interaction (Baddeley et al., 
2013) and can be studied reliably and ecologically valid in a laboratory setting (e.g., 
Mundt et al., 2012). Compared to non-depressed individuals, depressed patients have 
been found to show long and frequent pauses, low pitch variability, and frequent negative 
self-references during speech (Alpert et al., 2001; Mundt et al., 2012; Baddeley et al., 
2013). The number of pauses and pitch variability have been found to normalize after 
antidepressant treatment (Alpert et al., 2001; Mundt et al., 2012).  
 Another aspect of everyday social interaction is behavioral mimicry. Compared 
to healthy controls, depressed individuals mimic others’ emotions less (Wexler et al., 
1994). Low mimicry is thought to reflect low prosociality (Chartrand & van Baaren, 
2009). In non-depressed individuals, acute decreases in serotonin can reduce prosocial 
behavior in a computerized prisoner’s dilemma game (Wood et al., 2006). Acute decreas-
es in serotonin may also reduce other types of prosocial behavior such as mimicry.  
 
The following hypotheses were formulated concerning the effects of ATD on speech and 
behavioral mimicry: 
 
2.1 ATD will increase the number of pauses and pause duration, and decrease pitch 
variability. 
2.2 ATD will result in the use of more self-references, more negative words, and 
fewer positive words. 
2.3 ATD will lower behavioral mimicry. 
2.4 The effects of ATD on verbal behavior and behavioral mimicry will be more 
pronounced in FH+ individuals than in FH- individuals.  
 
The testing of these hypotheses is described in Chapter 5.   
Rationale 
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Study 2: Effects of repeated tryptophan administration on social 
interactions in daily life 
Studies on the effects of longer-term increases in brain serotonin on social functioning 
may help explain how antidepressants may help during treatment of MDD (cf. Figure 3). 
Previous studies used two weeks of tryptophan administration to assess the effects of 
increases in brain serotonin on social interactions and mood in everyday life (Moskowitz 
et al., 2001; aan het Rot et al., 2006). As tryptophan may result in few side effects (Mos-
kowitz et al., 2001; Thomson et al., 1982), as opposed to SSRIs, to increase brain seroto-
nin repeatedly in healthy individuals, giving tryptophan may be preferred over repeated 
administration of SSRIs.  
In high trait irritable individuals, two weeks of tryptophan administration re-
duced quarrelsome behavior, increased agreeable behavior, and improved mood (aan het 
Rot et al., 2006). Similar to high trait irritable individuals, FH+ individuals have an in-
creased risk for developing MDD (Sullivan et al., 2000). Yet, because FH+ individuals 
share genes and environments with their family member that is diagnosed with MDD, 
FH+ individuals may be more similar to MDD patients than high trait irritable individu-
als. Therefore, FH+ individuals may inform about the role of serotonin in social function-
ing in MDD even more than studies involving high trait irritable individuals (cf. aan het 
Rot et al., 2006).  
Ecologically valid assessment of social behavior and mood in real-life can be 
performed with the EMA methodology mentioned in Chapter 1 and at the beginning of 
the present chapter (e.g., Moskowitz et al., 2001; aan het Rot et al., 2006; Zuroff et al., 
2007). This method developed by Moskowitz (1994) is based on the interpersonal cir-
cumplex model, which organizes social behavior around two orthogonal axes (Carson, 
1969; Wiggins & Broughton, 1991). One axis encompasses dominant and submissive 
behaviors and the other axis encompasses agreeable and quarrelsome behaviors. The four 
behavioral dimensions are assessed using behaviors sampled from the Social Behavior 
Inventory (Moskowitz, 1994; aan het Rot, Hogenelst, & Moskowitz, 2013). The EMA 
method for assessing real-life social interactions has been extensively validated (Mos-
kowitz, 1994; Moskowitz & Sadikaj, 2012).  
In Study 2, EMA was used to assess the effects of repeated tryptophan admin-
istration on social behavior and mood during everyday social interactions of FH+ indi-
viduals. In contrast to Study 1, only FH+ individuals were included. Eleven FH+ individ-
uals who participated in Study 1 also participated in Study 2. Ideally all FH+ participants 
from Study 1 would have participated in Study 2, allowing comparison of social behavior 
assessed in the laboratory with social behavior assessed in everyday life (see also section 
Chapter 2 
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7.5, page 119). However, offering both Study 1 and Study 2 as one package was not 
feasible as this was too time consuming for some FH+ individuals. It was not necessary 
to include a comparison group in Study 2 as the results could be compared with previous 
studies (aan het Rot et al., 2006; Moskowitz et al., 2001). Similar to high trait irritable 
individuals (aan het Rot et al., 2006), tryptophan administration may positively influence 
the quality of social interactions in FH+ individuals, who have been shown to display 
poorer social functioning than FH- individuals (Watters et al., 2013). Positive changes in 
daily social behavior and perceptions of others may be expected to positively influence 
the way individuals think more generally about themselves in relation to others. In Study 
2 we explored this idea by adding a list of social cognitions to be rated at the end of each 
test day. This would allow us to determine whether the effects of tryptophan on interper-
sonal functioning would extend beyond the level of individual interactions. 
 
The following hypotheses were formulated: 
 
3.1 Tryptophan administration will decrease levels of quarrelsome behaviors and 
increase levels of agreeable behaviors. 
3.2  Tryptophan administration will improve mood. 
3.3 When taking tryptophan, individuals will have more positive and fewer negative 
thoughts about themselves in relation to others. 
 
The testing of these hypotheses is described in Chapter 6. 
 
In summary, Studies 1 and 2 were conducted to gain more insight in the role of serotonin 
in the regulation of social behavior and mood in individuals at familial risk for MDD. 
More specifically, studying the effects of acute reductions in brain serotonin on social 
behavior in FH+ individuals may help explain how reduced serotonin function may con-
tribute to MDD. Conversely, studying the effects of repeated increases in brain serotonin 
on social behavior in FH+ individuals may help explain how antidepressants may help 
during treatment of MDD (Figure 3). The implications of the studies’ findings are de-
scribed in Chapters 7 and 8. 
